www.lls.org
Open in
urlscan Pro
54.83.53.190
Public Scan
URL:
https://www.lls.org/blog?sfmc_id=225423329
Submission: On November 30 via api from US — Scanned from DE
Submission: On November 30 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMGET /search
<form class="views-exposed-form bef-exposed-form" data-bef-auto-submit-full-form="" data-bef-auto-submit="" data-bef-auto-submit-delay="500" data-drupal-selector="views-exposed-form-acquia-search-page" action="/search" method="get"
id="views-exposed-form-acquia-search-page" accept-charset="UTF-8">
<div class="js-form-item form-item js-form-type-textfield form-item-search js-form-item-search">
<label for="edit-search">Search</label>
<input placeholder="Search..." data-bef-auto-submit-exclude="" data-drupal-selector="edit-search" aria-describedby="edit-search--description" type="text" id="edit-search" name="search" value="" size="30" maxlength="128" class="form-text">
<div id="edit-search--description" class="description"> Search for topics. </div>
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-bef-auto-submit-click="" data-drupal-selector="edit-submit-acquia-search" type="submit" id="edit-submit-acquia-search"
value="Search" class="button js-form-submit form-submit">
</div>
</form>
GET /search
<form class="views-exposed-form bef-exposed-form" data-bef-auto-submit-full-form="" data-bef-auto-submit="" data-bef-auto-submit-delay="500" data-drupal-selector="views-exposed-form-acquia-search-page" action="/search" method="get"
id="views-exposed-form-acquia-search-page" accept-charset="UTF-8">
<div class="js-form-item form-item js-form-type-textfield form-item-search js-form-item-search">
<label for="edit-search--2">Search</label>
<input placeholder="Search..." data-bef-auto-submit-exclude="" data-drupal-selector="edit-search" aria-describedby="edit-search--2--description" type="text" id="edit-search--2" name="search" value="" size="30" maxlength="128" class="form-text">
<div id="edit-search--2--description" class="description"> Search for topics. </div>
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--2"><input data-bef-auto-submit-click="" data-drupal-selector="edit-submit-acquia-search-2" type="submit" id="edit-submit-acquia-search--2"
value="Search" class="button js-form-submit form-submit">
</div>
</form>
Text Content
Skip to main content MAIN NAVIGATION Donate * About LLS WHO WE ARE * Who We Are * Our History * Leadership * Financials * DEI Commitment OUR MISSION * Our Mission * Research * Policy & Advocacy * Patient Support CONTACT US * Contact Us * Our Regions * News Networks * Partner With LLS * Blogs * Work at LLS * Supplier Resources * Patients & Caregivers DISEASE INFORMATION * Disease Information * Leukemia * Lymphoma * Myeloma * Myelodysplastic Syndromes * Myeloproliferative Neoplasms * Facts and Statistics * Children and Young Adults * Newly Diagnosed * Managing Your Cancer * Treatment * Clinical Trials SUPPORT RESOURCES * Support Resources * Contact an Information Specialist * Financial Support * Online Chats * Support Groups * Peer-to-Peer Support * Caregiver Support * Nutrition Consultations * LLS Patient Community * Podcast * Other Helpful Organizations * Suggested Reading * LLS Health Manager App EDUCATION RESOURCES * Education Resources * COVID-19 Resources * Informational Booklets * Webcasts * Videos * 3D Model Library * Drug Listings * Blood Cancer Conferences * Researchers & Healthcare Professionals LLS RESEARCH * LLS Research * Research Grant Programs * Apply for an Academic Grant * Project Finder * Who We Fund THERAPY ACCELERATION PROGRAM * Therapy Acceleration Program * Portfolio * The Team * Latest News * How to Apply RESOURCES FOR HCPS * Resources for HCPs * Continuing Education Programs * Continuing Medical Education Programs * Free Publications * Podcast * Patient Referral Form * The Trish Greene Back to School Program * Dare to Dream Project * How To Help WAYS TO GIVE * Ways to Give * Donate Online * Donate by Mail * Donate Cryptocurrency * Donor-Advised Funds * Employee Matching Gifts * Wills, Trusts and Annuities * Stock Transfer * Tribute Gifts FUNDRAISE * Fundraise * Fundraising Events * Create a Tribute Page * Create Your Own Fundraiser VOLUNTEER * Volunteer * Become a Volunteer * Volunteer LLS Portal * Volunteer Grants ADVOCATE * Advocate * Take Action * Sign Up to Be an Advocate SHOP * Shop * LLS Store * Charitable Shopping * Search SEARCH Search Search for topics. * Donate * En Espanol MAIN NAVIGATION (MOBILE) * About LLS * Who We Are * Who We Are * Our History * Leadership * Financials * DEI Commitment * Our Mission * Our Mission * Research * Policy & Advocacy * Patient Support * Contact Us * Contact Us * Our Regions * News Networks * Partner With LLS * Blogs * Work at LLS * Supplier Resources * Patients & Caregivers * Disease Information * Disease Information * Leukemia * Lymphoma * Myeloma * Myelodysplastic Syndromes * Myeloproliferative Neoplasms * Facts and Statistics * Children and Young Adults * Newly Diagnosed * Managing Your Cancer * Treatment * Clinical Trials * Support Resources * Support Resources * Contact an Information Specialist * Financial Support * Online Chats * Support Groups * Peer-to-Peer Support * Caregiver Support * Nutrition Consultations * LLS Patient Community * Podcast * Other Helpful Organizations * Suggested Reading * LLS Health Manager App * Education Resources * Education Resources * COVID-19 Resources * Informational Booklets * Webcasts * Videos * 3D Model Library * Drug Listings * Blood Cancer Conferences * Researchers & Healthcare Professionals * LLS Research * LLS Research * Research Grant Programs * Apply for an Academic Grant * Project Finder * Who We Fund * Therapy Acceleration Program * Therapy Acceleration Program * Portfolio * The Team * Latest News * How to Apply * Resources for HCPs * Resources for HCPs * Continuing Education Programs * Continuing Medical Education Programs * Free Publications * Podcast * Patient Referral Form * The Trish Greene Back to School Program * Dare to Dream Project * How To Help * Ways to Give * Ways to Give * Donate Online * Donate by Mail * Donate Cryptocurrency * Donor-Advised Funds * Employee Matching Gifts * Wills, Trusts and Annuities * Stock Transfer * Tribute Gifts * Fundraise * Fundraise * Fundraising Events * Create a Tribute Page * Create Your Own Fundraiser * Volunteer * Volunteer * Become a Volunteer * Volunteer LLS Portal * Volunteer Grants * Advocate * Advocate * Take Action * Sign Up to Be an Advocate * Shop * Shop * LLS Store * Charitable Shopping * Search SEARCH Search Search for topics. * Donate * En Espanol THE LLS BLOG Read about survivors, research, fundraising and advocacy. LLS AND VOLUNTEERS CHEER CALIFORNIA LAWS PROMOTING HEALTH EQUITY Posted On: October 3, 2022 LLS and blood cancer advocates are celebrating after our efforts helped make two bills become law in California, advancing health equity and improving cancer care for thousands. Read More HOW LLS AND ADVOCATES HELPED SECURE LANDMARK HEALTH REFORMS Posted On: August 17, 2022 Today, cancer patients—and others with other chronic conditions—are breathing a collective sigh of relief. After years of relentless efforts by LLS staff and blood cancer advocates, President Biden just signed into law the Inflation Reduction Act and its key health provisions which will make healthcare more affordable for millions. Read More FDA APPROVES NEW OPTION FOR DIFFICULT TO TREAT, RARE FORM OF CHILDHOOD LEUKEMIA Posted On: May 26, 2022 The Food and Drug Administration (FDA) approved azacitidine (Vidaza®) for pediatric patients 1 month and older with newly diagnosed juvenile myelomonocytic leukemia (JMML). JMML is an aggressive and difficult to treat disease. Read More MORE THAN 5 MILLION NEW YORKERS ARE GETTING "IN-NETWORK" ACCESS TO TOP CANCER CENTERS Posted On: April 13, 2022 New York’s newly-signed budget contains a key reform that could be nothing short of lifesaving for some cancer patients living in the state. National Cancer Institute-designated cancer centers will become “in-network” for over 5 million New Yorkers who rely on Medicaid, Essential, or Marketplace plans. Read More CAR T-CELL THERAPY APPROVED FOR INITIAL TREATMENT OF RELAPSED LARGE B-CELL LYMPHOMA Posted On: April 5, 2022 The U.S. Food and Drug Administration (FDA) last week approved axicabtagene ciloleucel (axi-cel, Yescarta®) for patients with large B-cell lymphoma (LBCL) who either did not respond to first-line standard chemotherapy or relapsed within 12 months. This is a big step for CAR T because it is now proven that CAR T-therapy can outperform the best therapy we had for certain patients that failed initial therapy. Read More OLDER POSTS PAGINATION * Current page 1 * Page 2 * Page 3 * Page 4 * Page 5 * Page 6 * Page 7 * Page 8 * Page 9 * … * Next page ›› * Last page » FOLLOW US * * * * * * * STAY INFORMED Subscribe The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions. Tax Identification Number: 13-5644916 * * * * * * FOOTER * Privacy Policy * Security * Copyright * Link Policy * Disclaimer * Public Disclosure * Fundraising Disclosure * Refund Policy * Work at LLS * Contact Us * En Espanol * LLS Canada * Sweepstakes Rules * Community Guidelines